Document
IPR2016-01129, No. 1096-142 Exhibit - Exhibit 1096 Mrukwa Kominek et al NCBI Effect of Anti Inflamm Therapy (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01129, No. 1096-142 Exhibit - Exhibit 1096 Mrukwa Kominek et al NCBI Effect of Anti Inflamm Therapy (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01129, No. 1105-151 Exhibit - Exhibit 1105 Allergan Q3 2013 Earnings Call (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01129, No. 1105-151 Exhibit - Exhibit 1105 Allergan Q3 2013 Earnings Call (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01129, No. 2082-196 Exhibit - REPLACEMENT Deposition transcript of Andrew F Calman, MD, PhD with Errata (P.T.A.B. Aug. 16, 2017)
Cite Document
IPR2016-01129, No. 2082-196 Exhibit - REPLACEMENT Deposition transcript of Andrew F Calman, MD, PhD with Errata (P.T.A.B. Aug. 16, 2017)
+ More Snippets
Document
IPR2016-01129, No. 2031-47 Exhibit - Allergan ¿¿¿ NYSE AGN ¿¿¿ Company Profile (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01129, No. 2031-47 Exhibit - Allergan ¿¿¿ NYSE AGN ¿¿¿ Company Profile (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01129, No. 2049-60 Exhibit - Allergan Inc, SalomonSmithBarney Equity Research Report, Feb 12, 2003 (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01129, No. 2049-60 Exhibit - Allergan Inc, SalomonSmithBarney Equity Research Report, Feb 12, 2003 (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01129, No. 2021-38 Exhibit - Approved Drug Products with Therapeutic Equivalence Evaluations (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01129, No. 2021-38 Exhibit - Approved Drug Products with Therapeutic Equivalence Evaluations (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01129, No. 1038-90 Exhibit - REDACTED Exhibit 1038 Attar Deposition Transcript (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01129, No. 1038-90 Exhibit - REDACTED Exhibit 1038 Attar Deposition Transcript (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01129, No. 1059-105 Exhibit - Exhibit 1059 Foulks et al 2007 DEWS dry eye study report (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01129, No. 1059-105 Exhibit - Exhibit 1059 Foulks et al 2007 DEWS dry eye study report (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01129, No. 1046-92 Exhibit - Exhibit 1046 Niederkorn et al (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01129, No. 1046-92 Exhibit - Exhibit 1046 Niederkorn et al (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01129, No. 1087-133 Exhibit - Exhibit 1087 Schachet the golden age of dry eye (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01129, No. 1087-133 Exhibit - Exhibit 1087 Schachet the golden age of dry eye (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01129, No. 1115-161 Exhibit - Exhibit 1115 Allergan Q4 2015 Earnings Transcript (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01129, No. 1115-161 Exhibit - Exhibit 1115 Allergan Q4 2015 Earnings Transcript (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01129, No. 1149-231 Exhibit - EX1149 Health Care Alliances Letter (P.T.A.B. Oct. 13, 2017)
Cite Document
IPR2016-01129, No. 1149-231 Exhibit - EX1149 Health Care Alliances Letter (P.T.A.B. Oct. 13, 2017)
+ More Snippets
Document
IPR2016-01129, No. 1072-118 Exhibit - Exhibit 1072 Allergan Inc 2002 10 K (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01129, No. 1072-118 Exhibit - Exhibit 1072 Allergan Inc 2002 10 K (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01129, No. 1116-162 Exhibit - Exhibit 1116 Restasis Program Benefits (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01129, No. 1116-162 Exhibit - Exhibit 1116 Restasis Program Benefits (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01129, No. 1171-268 Exhibit - EX1171 HR098P1PS Excerpts (P.T.A.B. Mar. 14, 2018)
Cite Document
IPR2016-01129, No. 1171-268 Exhibit - EX1171 HR098P1PS Excerpts (P.T.A.B. Mar. 14, 2018)
+ More Snippets